Melior Pharmaceuticals Announces Positive Phase 2A Results in Type 2 Diabetes Study

Previous PostRelmada Therapeutics Announces Notice of Allowance for U.S. Patent Covering d-Methadone, an NMDA Receptor Antagonist, for the Treatment of Depression